A wrongful death lawsuit alleges the company fostered a risky culture of drug use among some leaders and employees, claiming ...

The use of ketamine to treat severe depression was approved in Singapore in October 2020, to be administered as a nasal spray together with oral anti-depressant therapy. Clinical trials have shown ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

The Department of Defense is funding research being carried out by the Larner College of Medicine and UVM Medical Center into ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...

The 25-year-old is now semi-conscious in hospital, unable to move or speak, and can only track things with her eyes ...

A recent study from researchers at Colorado State University looked into the biggest causes of depression in middle-aged and ...

Two theories behind the biological basis of depression have battled it out for decades — which one will emerge victorious?

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics ...